Cellectis
CLLS
#7480
Rank
โ‚น38.23 B
Marketcap
โ‚น380.10
Share price
5.03%
Change (1 day)
215.43%
Change (1 year)

Market capitalization of Cellectis (CLLS)

Market cap: โ‚น38.23 Billion

As of February 2026 Cellectis has a market cap of โ‚น38.23 Billion. This makes Cellectis the world's 7480th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cellectis from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น38.23 B-10.62%
2025โ‚น42.77 B246.68%
2024โ‚น12.33 B-32.77%
2023โ‚น18.35 B126.65%
2022โ‚น8.09 B-71.6%
2021โ‚น28.51 B-69.42%
2020โ‚น93.24 B75.32%
2019โ‚น53.18 B3.93%
2018โ‚น51.17 B-20.48%
2017โ‚น64.35 B56.41%
2016โ‚น41.14 B-42.34%
2015โ‚น71.36 B157.11%
2014โ‚น27.75 B570.96%
2013โ‚น4.13 B

End of Day market cap according to different sources

On Feb 24th, 2026 the market cap of Cellectis was reported to be:

โ‚น26.09 Billion
by Nasdaq info icon info icon
โ‚น36.40 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regeneron Pharmaceuticals
REGN
โ‚น7.539 T 19,619.33%๐Ÿ‡บ๐Ÿ‡ธ USA
uniQure
QURE
โ‚น140.87 B 268.44%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Novavax
NVAX
โ‚น140.81 B 268.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
โ‚น41.73 B 9.15%๐Ÿ‡บ๐Ÿ‡ธ USA